Table 5.
Total | I (no risk factors) | II (prehabilitated patients) | p | |
---|---|---|---|---|
n | 259 | 133 | 126 | |
SSO (n,%) | 87 (34) | 43 (32) | 44 (35) | 0.659 |
Seroma I–II (n,%) | 22 (8) | 9 (7) | 13 (10) | 0.306 |
Seroma III–IV (n,%) | 19 (7) | 10 (8) | 9 (7) | 0.908 |
Hematoma I–II (n,%) | 28 (11) | 12 (9) | 16 (13) | 0.341 |
Hematoma III–IV (n,%) | 8 (3) | 3 (2) | 5 (4) | 0.426 |
SSE | 18 (7) | 6 (5) | 12 (10) | 0.113 |
SSI | 31 (12) | 14 (11) | 17 (13) | 0.462 |
SSOPI | 13 (5) | 6 (5) | 7 (6) | 0.700 |
Systemic complications | ||||
0 (n,%) | 165 (64) | 81 (61) | 84 (67) | 0.190 |
1 (n,%) | 60 (23) | 31 (23) | 29 (23) | |
2 (n,%) | 17 (7) | 13 (10) | 4 (3) | |
> 2 (n,%) | 17 (7) | 8 (6) | 9 (7) | |
Airway infection (n,%) | 54 (21) | 28 (21) | 26 (21) | 0.934 |
Pulmonary embolism (n,%) | 6 (34) | 5 (4) | 1 (34) | 0.113 |
Gastrointestinal (n,%) | 24 (9) | 10 (8) | 14 (11) | 0.319 |
Cardial (n,%) | 10 (4) | 7 (5) | 3 (34) | 0.229 |
Other complications (n,%) | 45 (17) | 24 (18) | 21 (17) | 0.769 |
Mortality (n,%) | 4 (2) | 3 (2) | 1 (1) | 0.340 |
Length of stay (median, QR) | 6 (5–8) | 6 (5–8) | 6 (5–8) | 0.401 |
Admission > 7 days (n,%) | 57 (22) | 27 (20) | 30 (24) | 0.496 |
Reoperation (n,%) | 14 (5) | 4 (3) | 10 (8) | 0.079 |
Readmission (n,%) | 12 (5) | 4 (3) | 8 (6) | 0.201 |
SSO surgical site occurrence, seroma/hematoma I–II no clinical significance, seroma/hematoma III–IV clinical significance- needing intervention, SSE surgical site event, SSI surgical site infection, SSOPI surgical site occurrence requiring procedural interventions